Your browser doesn't support javascript.
loading
Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy.
Jaikuna, Tanwiwat; Osorio, Eliana Vasquez; Azria, David; Chang-Claude, Jenny; De Santis, Maria Carmen; Gutiérrez-Enríquez, Sara; van Herk, Marcel; Hoskin, Peter; Lambrecht, Maarten; Lingard, Zoe; Seibold, Petra; Seoane, Alejandro; Sperk, Elena; Symonds, R Paul; Talbot, Christopher J; Rancati, Tiziana; Rattay, Tim; Reyes, Victoria; Rosenstein, Barry S; de Ruysscher, Dirk; Vega, Ana; Veldeman, Liv; Webb, Adam; West, Catharine M L; Aznar, Marianne C.
Affiliation
  • Jaikuna T; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol U
  • Osorio EV; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.
  • Azria D; Department of Radiation Oncology, Montpellier Cancer Institute, Université Montpellier, Inserm, U1194, France.
  • Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Germany.
  • De Santis MC; Radiation Oncology, Fondazione IRCCS Isituto Nazionale dei Tumori, Milan, Italy.
  • Gutiérrez-Enríquez S; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, Barcelona, Spain.
  • van Herk M; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.
  • Hoskin P; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.
  • Lambrecht M; KU Leuven, Department of Radiation Oncology, Leuven, Belgium.
  • Lingard Z; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.
  • Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Seoane A; Medical Physics Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Sperk E; Department of Radiation Oncology, Mannheim Cancer Center, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Symonds RP; Leicester Cancer Research Centre, University of Leicester, United Kingdom.
  • Talbot CJ; Leicester Cancer Research Centre, University of Leicester, United Kingdom.
  • Rancati T; Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rattay T; Leicester Cancer Research Centre, University of Leicester, United Kingdom.
  • Reyes V; Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Rosenstein BS; Department of Radiation Oncology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.
  • de Ruysscher D; Maastricht University Medical Center, Department of Radiation Oncology (Maastro Clinic), GROW School for Oncology and Developmental Biology, Maastricht, the Netherlands.
  • Vega A; Fundación Pública Galega de Medicina Xenómica, Grupo de Medicina Xenómica (USC), Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de, Santiago de Compostela, Spain; Biomedical Network on Rare Diseases (CIBERER), Spain.
  • Veldeman L; Ghent University Hospital, Department of Radiation Oncology, Ghent, Belgium.
  • Webb A; Department of Genetics and Genome Biology, University of Leicester, United Kingdom.
  • West CML; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.
  • Aznar MC; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom. Electronic address: Marianne.aznar@manchester.ac.uk.
Breast ; 72: 103578, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37713940
ABSTRACT

BACKGROUND:

Normal tissue complication probability (NTCP) models can be useful to estimate the risk of fibrosis after breast-conserving surgery (BCS) and radiotherapy (RT) to the breast. However, they are subject to uncertainties. We present the impact of contouring variation on the prediction of fibrosis. MATERIALS AND

METHODS:

280 breast cancer patients treated BCS-RT were included. Nine Clinical Target Volume (CTV) contours were created for each patient i) CTV_crop (reference), cropped 5 mm from the skin and ii) CTV_skin, uncropped and including the skin, iii) segmenting the 95% isodose (Iso95%) and iv) 3 different auto-contouring atlases generating uncropped and cropped contours (Atlas_skin/Atlas_crop). To illustrate the impact of contour variation on NTCP estimates, we applied two equations predicting fibrosis grade ≥ 2 at 5 years, based on Lyman-Kutcher-Burman (LKB) and Relative Seriality (RS) models, respectively, to each contour. Differences were evaluated using repeated-measures ANOVA. For completeness, the association between observed fibrosis events and NTCP estimates was also evaluated using logistic regression.

RESULTS:

There were minimal differences between contours when the same contouring approach was followed (cropped and uncropped). CTV_skin and Atlas_skin contours had lower NTCP estimates (-3.92%, IQR 4.00, p < 0.05) compared to CTV_crop. No significant difference was observed for Atlas_crop and Iso95% contours compared to CTV_crop. For the whole cohort, NTCP estimates varied between 5.3% and 49.5% (LKB) or 2.2% and 49.6% (RS) depending on the choice of contours. NTCP estimates for individual patients varied by up to a factor of 4. Estimates from "skin" contours showed higher agreement with observed events.

CONCLUSION:

Contour variations can lead to significantly different NTCP estimates for breast fibrosis, highlighting the importance of standardising breast contours before developing and/or applying NTCP models.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Fibrocystic Breast Disease Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Fibrocystic Breast Disease Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2023 Document type: Article